Aron M. Knickerbocker
2017
In 2017, Aron M. Knickerbocker earned a total compensation of $7.1M as President and Chief Executive Officer at Five Prime Therapeutics, a 45% increase compared to previous year.
Compensation breakdown
| Bonus | $107,500 |
|---|---|
| Non-Equity Incentive Plan | $190,860 |
| Option Awards | $5,586,258 |
| Salary | $433,750 |
| Stock Awards | $809,859 |
| Other | $6,000 |
| Total | $7,134,227 |
Knickerbocker received $5.6M in option awards, accounting for 78% of the total pay in 2017.
Knickerbocker also received $107.5K in bonus, $190.9K in non-equity incentive plan, $433.8K in salary, $809.9K in stock awards and $6K in other compensation.
Rankings
In 2017, Aron M. Knickerbocker's compensation ranked 1,130th out of 14,666 executives tracked by ExecPay. In other words, Knickerbocker earned more than 92.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,130 out of 14,666 | 92nd |
Division Manufacturing | 378 out of 5,770 | 93rd |
Major group Chemicals And Allied Products | 100 out of 2,074 | 95th |
Industry group Drugs | 67 out of 1,730 | 96th |
Industry Pharmaceutical Preparations | 54 out of 1,329 | 96th |
Source: SEC filing on March 30, 2018.
Knickerbocker's colleagues
We found four more compensation records of executives who worked with Aron M. Knickerbocker at Five Prime Therapeutics in 2017.